Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Current Assets (2020 - 2026)

Bioventus filings provide 6 years of Current Assets readings, the most recent being $272.8 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 1.0% to $272.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $272.8 million, a 1.0% decrease, with the full-year FY2025 number at $272.8 million, down 1.0% from a year prior.
  • Current Assets hit $272.8 million in Q4 2025 for Bioventus, down from $280.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $308.9 million in Q2 2024 to a low of $245.4 million in Q2 2022.
  • Median Current Assets over the past 5 years was $271.8 million (2022), compared with a mean of $272.5 million.
  • Biggest five-year swings in Current Assets: rose 25.78% in 2023 and later fell 13.85% in 2024.
  • Bioventus' Current Assets stood at $263.1 million in 2021, then increased by 3.6% to $272.6 million in 2022, then decreased by 1.68% to $268.0 million in 2023, then grew by 2.84% to $275.6 million in 2024, then decreased by 1.0% to $272.8 million in 2025.
  • The last three reported values for Current Assets were $272.8 million (Q4 2025), $280.9 million (Q3 2025), and $275.2 million (Q2 2025) per Business Quant data.